Skip to content

Clinical trials

Myelodysplastic Syndromes trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Country / region: Taiwan Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20082
20091
20101
20111
20141
20162
20194
20203
20221
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting5
Terminated4
Active, not recruiting3
Unknown status2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Celgene3
Bristol-Myers Squibb2
Takeda2
AbbVie1
Eli Lilly and Company1
GlaxoSmithKline1
Gruppo Italiano Malattie EMatologiche dell'Adulto1
Hemavant Sciences GmbH1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes23
Leukemia, Myeloid, Acute7
Anemia4
Myeloproliferative Disorders4
Leukemia, Myelomonocytic, Chronic3
Thrombocytopenia3
Anemia, Diamond-Blackfan2
Neoplasms2
Thalassemia2
Anemia, Aplastic1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.